18 algorithm-development "https:" "Simons Foundation" Master positions at Universidade de Coimbra
Sort by
Refine Your Search
-
to be achieved: Development of algorithms for analyzing facial expressions in static and video images. Analysis and evaluation of identity bias in facial expression recognition. V - Initial grant duration
-
of RBI-FCT, they are developed in association or cooperation between the higher education institution and one or more R&D units. [JB3.1] I.III - [JB4.1] Ineligible candidates: Candidates enrolled in non
-
that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation between the higher education institution and one or more R&D units. I.III - Ineligible candidates
-
subparagraph e) of paragraph 3 of Article 4 of Decree-Law No. 74/2006, in its current wording, provided that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation
-
for the piloting, demonstration and scale-up of innovative seaweed/algae-based solutions and ecosystem building. Where to apply Website https://apply.uc.pt/ Requirements Research FieldBiological sciences
-
subparagraph e) of paragraph 3 of Article 4 of Decree-Law No. 74/2006, in its current wording, provided that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation
-
paragraph 3 of Article 4 of Decree-Law No. 74/2006, in its current wording, provided that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation between the higher
-
: This scholarship is part of the PULSE project. This project aims to develop artificial intelligence-based solutions for non-invasive assessment of the heart's electromechanical activity using heart sounds
-
-Law No. 74/2006, in its current wording, provided that, under subparagraph e) of Article 3 of RBI-FCT, they are developed in association or cooperation between the higher education institution and one
-
position(s), under the project CAPACITY 2023, title Consortium for Developing Regulatory Capacity for Clinical Trials using Gene Therapy products and Strengthening Pharmacovigilance in the Conduct